サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
表紙：血漿タンパク質治療薬市場：製品タイプ別、用途別、国別、地域別- 産業分析、市場規模、市場シェア、2024-2032年予測
市場調査レポート
商品コード
1419029

血漿タンパク質治療薬市場：製品タイプ別、用途別、国別、地域別- 産業分析、市場規模、市場シェア、2024-2032年予測

Plasma Protein Therapeutic Market, By Product Type, By Application, By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2024-2032
出版日: | 発行: AnalystView Market Insights | ページ情報: 英文 291 Pages | 納期: 2～3営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=156.76円
血漿タンパク質治療薬市場：製品タイプ別、用途別、国別、地域別- 産業分析、市場規模、市場シェア、2024-2032年予測
出版日: 2024年01月21日
発行: AnalystView Market Insights
ページ情報: 英文 291 Pages
納期: 2～3営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

レポートハイライト

血漿タンパク質治療薬市場規模は2023年に300億5,300万米ドルとなり、2024年から2032年にかけてCAGR 6.5％で拡大する見込みです。

血漿タンパク質治療薬市場- 市場力学

自己免疫疾患、免疫不全疾患、神経疾患、出血性疾患の増加が市場の成長を促進すると予測されます。

血漿由来免疫グロブリンなどの血漿タンパク質治療薬は、特定の自己免疫疾患の治療に利用されます。自己免疫疾患の有病率の増加は、血漿ベースの治療薬に対する需要の増加に寄与し、それによって市場の拡大を推進しています。スカンジナビア諸国など、疫学的資源が豊富な国々から収集した包括的調査とデータに基づくと、自己免疫疾患は米国人口の約3％、約1,000万人が罹患していると推定されます。この推定をより理解するために、米国の現在の人口3億2,900万人を考慮しています。さらに、免疫不全疾患、神経疾患、出血性疾患の発生率が急増し、治療介入を必要とする患者数が増加することが予想されます。特に神経疾患の有病率は、これらの治療オプションの需要を促進する可能性があります。国内のさまざまな地域におけるさまざまな神経疾患の有病率は、人口10万人当たり967～4,070人で、平均は2,394人となっており、3,000万人以上が神経疾患の影響を受けていることがわかる。さらに、組換えタンパク質や人工血漿タンパク質の開発など、治療技術の進歩が進んでいるため、市場において技術革新の機会がもたらされています。しかし、治療費が高く、汚染や伝播の潜在的リスクが市場の成長を阻害する可能性があることに留意することが重要です。

血漿タンパク質治療薬市場-セグメンテーション分析：

世界の血漿タンパク質治療薬市場は、製品タイプ、用途、地域によって区分されます。

市場は製品タイプに基づいて3つのカテゴリーに分けられる：アルブミン、免疫グロブリン、血漿由来第VIII因子、その他。市場は、免疫グロブリンセグメントの優位性によって大きな影響を受けています。免疫グロブリン製品は、免疫不全疾患、自己免疫疾患、神経疾患など様々な疾患の治療に不可欠であるため、血漿タンパク質治療薬市場において重要な位置を占めています。

市場は用途によって2つのカテゴリーに分けられる：すなわち、血友病、原発性免疫不全症（PIDD）、特発性血小板減少性紫斑病（ITP）、その他です。市場は主に原発性免疫不全症（PIDD）のセグメントで占められています。PIDDの場合、免疫系が低下しているため、患者は抗体の欠乏を頻繁に経験します。ヒト血漿を原料とする免疫グロブリン補充療法は、PIDDの管理において重要な役割を果たしています。この療法では、患者の免疫反応を強化するために免疫グロブリンを投与します。

血漿タンパク質治療薬市場-地理的洞察

地理的に、この市場は北米、ラテンアメリカ、欧州、アジア太平洋、中東・アフリカなど様々な地域に広がっています。これらの地域は、事業活動を行っている国に基づいてさらに区分されます。市場の成長はアジア太平洋地域が支配的であると予想されるが、その主な理由は、医療インフラが確立されていることと、血漿タンパク質治療薬の研究開発に市場関係者が注力していることです。近年、アジア太平洋地域では医療インフラが大きく成長し、医療施設、病院、研究センターへの投資が行われ、ヘルスケア・エコシステム全体の改善に寄与しています。特筆すべきは、中国政府が強固なヘルスケア・システムの確立に成功したことで、世界最大の発展途上国である同国の地位を考慮すれば、これは極めて課題的なことです。歴代政府の継続的な努力により、中国本土では2021年末までに、36,570の病院と977,790の一次レベルの診療所を含む、合計1,030,935のヘルスケア機関が整備されると予測されています。市場規模では、欧州が予測期間中第2位の地位を占めており、これは高度な治療オプションに対する需要の増加と新興経済諸国の成長に牽引されています。

血漿タンパク質治療薬市場-競合情勢：

従来の製薬業界とは対照的に、血漿業界は生命を救う医薬品を製造するための主要材料として、生体細胞であるヒト血漿を利用しています。これらの医薬品の生産は、限られた原料供給に依存しており、一般に、バイオテクノロジー施設で培養された非生体分子や生物製剤に比べ、入手が高価で複雑です。市場競争力を維持するためには、継続的な研究開発努力が不可欠です。企業は、血漿由来の新製品や改良品の開発、製造工程の強化、新たな治療用途の開拓に向けて投資を行う。より安全で持続可能な治療法に対する需要の高まりに対応するため、組換えタンパク質の開発などバイオテクノロジーの進歩は多くの企業にとって重要な分野です。世界に事業を展開する企業は、多様な市場へのアクセスに有利です。製造施設、流通網、パートナーシップを構築し、様々な地域で製品を入手できるようにしています。血漿由来療法の需要が高まり続ける中、企業は競争力を維持するため、研究開発への投資、戦略的パートナーシップの開拓、進化する市場力学への適応に粘り強く取り組んでいくものと思われます。

最近の進展

2023年5月、バイオテストAGは、チェコ共和国、スロバキア、リトアニア、アイルランド、ルーマニアの5カ国で、CMVハイパー免疫グロブリン製剤サイトテクトの販売承認を取得し、28カ国で販売を開始しました。

目次

第1章 血漿タンパク質治療薬市場概要

  • 調査範囲
  • 市場推定年数

第2章 エグゼクティブサマリー

  • 市場内訳
  • 競合考察

第3章 血漿タンパク質治療薬の主要な市場動向

  • 市場促進要因
  • 市場抑制要因
  • 市場機会
  • 今後の市場動向

第4章 血漿タンパク質治療薬産業の研究

  • PEST分析
  • ポーターのファイブフォース分析
  • 成長見通しのマッピング
  • 規制枠組みの分析

第5章 血漿タンパク質治療薬市場：COVID-19の影響分析

  • COVID-19前の影響分析
  • COVID-19後の影響分析

第6章 血漿タンパク質治療薬市場情勢

  • 血漿タンパク質治療薬市場シェア分析、2022年
  • 主要メーカー別の内訳データ
    • 既存企業の分析
    • 新興企業の分析

第7章 血漿タンパク質治療薬市場- 製品タイプ別

  • 概要
    • 製品タイプ別セグメントシェア分析
    • アルブミン
    • 免疫グロブリン
    • 血漿由来第VIII因子
    • その他

第8章 血漿タンパク質治療薬市場- 用途別

  • 概要
    • 用途別のセグメントシェア分析
    • 血友病
    • 原発性免疫不全障害（PIDD）
    • 特発性血小板減少性紫斑病（ITP）
    • その他

第9章 血漿タンパク質治療薬市場- 地域別

  • イントロダクション
  • 北米
    • 概要
    • 北米の主要メーカー
    • 米国
    • カナダ
  • 欧州
    • 概要
    • 欧州の主要メーカー
    • ドイツ
    • イタリア
    • 英国
    • フランス
    • ロシア
    • オランダ
    • スウェーデン
    • ポーランド
    • その他
  • アジア太平洋（APAC）
    • 概要
    • アジア太平洋地域の主要メーカー
    • インド
    • 中国
    • 日本
    • 韓国
    • オーストラリア
    • タイ
    • インドネシア
    • フィリピン
    • その他
  • ラテンアメリカ
    • 概要
    • ラテンアメリカの主要メーカー
    • ブラジル
    • メキシコ
    • アルゼンチン
    • コロンビア
    • その他
  • 中東とアフリカ
    • 概要
    • 中東およびアフリカの主要メーカー
    • サウジアラビア
    • アラブ首長国連邦
    • イスラエル
    • トルコ
    • アルジェリア
    • エジプト
    • その他

第10章 主要ベンダー分析- 血漿タンパク質治療薬産業

  • 競合ダッシュボード
  • 企業プロファイル
    • CSL
    • Grifols, SA
    • Takeda
    • Octapharma AG
    • Biotest AG
    • Kedrion SpA

第11章 アナリストの全方位展望

図表

List of Tables

  • TABLE List of data sources
  • TABLE Market drivers; Impact Analysis
  • TABLE Market restraints; Impact Analysis
  • TABLE Plasma Protein Therapeutic Market: Product Type Snapshot (2022)
  • TABLE Segment Dashboard; Definition and Scope, by Product Type
  • TABLE Global Plasma Protein Therapeutic Market, by Product Type 2018-2030 (USD Million)
  • TABLE Plasma Protein Therapeutic Market: Application Snapshot (2022)
  • TABLE Segment Dashboard; Definition and Scope, by Application
  • TABLE Global Plasma Protein Therapeutic Market, by Application 2018-2030 (USD Million)
  • TABLE Plasma Protein Therapeutic Market: Regional snapshot (2022)
  • TABLE Segment Dashboard; Definition and Scope, by Region
  • TABLE Global Plasma Protein Therapeutic Market, by Region 2018-2030 (USD Million)
  • TABLE North America Plasma Protein Therapeutic Market, by Country, 2018-2030 (USD Million)
  • TABLE North America Plasma Protein Therapeutic Market, by Product Type, 2018-2030 (USD Million)
  • TABLE North America Plasma Protein Therapeutic Market, by Application, 2018-2030 (USD Million)
  • TABLE Europe Plasma Protein Therapeutic Market, by Country, 2018-2030 (USD Million)
  • TABLE Europe Plasma Protein Therapeutic Market, by Product Type, 2018-2030 (USD Million)
  • TABLE Europe Plasma Protein Therapeutic Market, by Application, 2018-2030 (USD Million)
  • TABLE Asia Pacific Plasma Protein Therapeutic Market, by Country, 2018-2030 (USD Million)
  • TABLE Asia Pacific Plasma Protein Therapeutic Market, by Product Type, 2018-2030 (USD Million)
  • TABLE Asia Pacific Plasma Protein Therapeutic Market, by Application, 2018-2030 (USD Million)
  • TABLE Latin America Plasma Protein Therapeutic Market, by Country, 2018-2030 (USD Million)
  • TABLE Latin America Plasma Protein Therapeutic Market, by Product Type, 2018-2030 (USD Million)
  • TABLE Latin America Plasma Protein Therapeutic Market, by Application, 2018-2030 (USD Million)
  • TABLE Middle East and Africa Plasma Protein Therapeutic Market, by Country, 2018-2030 (USD Million)
  • TABLE Middle East and Africa Plasma Protein Therapeutic Market, by Product Type, 2018-2030 (USD Million)
  • TABLE Middle East and Africa Plasma Protein Therapeutic Market, by Application, 2018-2030 (USD Million)

List of Figures

  • FIGURE Plasma Protein Therapeutic Market Segmentation
  • FIGURE Market research methodology
  • FIGURE Value chain analysis
  • FIGURE Porter's Five Forces Analysis
  • FIGURE Market Attractiveness Analysis
  • FIGURE COVID-19 Impact Analysis
  • FIGURE Pre & Post COVID-19 Impact Comparision Study
  • FIGURE Competitive Landscape; Key company market share analysis, 2022
  • FIGURE Product Type segment market share analysis, 2022 & 2030
  • FIGURE Product Type segment market size forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Application segment market share analysis, 2022 & 2030
  • FIGURE Application segment market size forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Regional segment market share analysis, 2022 & 2030
  • FIGURE Regional segment market size forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE North America Plasma Protein Therapeutic Market share and leading players, 2022
  • FIGURE Europe Plasma Protein Therapeutic Market share and leading players, 2022
  • FIGURE Asia Pacific Plasma Protein Therapeutic Market share and leading players, 2022
  • FIGURE Latin America Plasma Protein Therapeutic Market share and leading players, 2022
  • FIGURE Middle East and Africa Plasma Protein Therapeutic Market share and leading players, 2022
  • FIGURE North America market share analysis by country, 2022
  • FIGURE U.S. Plasma Protein Therapeutic Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Canada Plasma Protein Therapeutic Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Europe Plasma Protein Therapeutic Market share analysis by country, 2022
  • FIGURE Germany Plasma Protein Therapeutic Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Spain Plasma Protein Therapeutic Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Italy Plasma Protein Therapeutic Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE France Plasma Protein Therapeutic Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE UK Plasma Protein Therapeutic Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Russia Plasma Protein Therapeutic Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Netherlands Plasma Protein Therapeutic Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Sweden Plasma Protein Therapeutic Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Poland Plasma Protein Therapeutic Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Rest of the Europe Plasma Protein Therapeutic Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Asia Pacific Plasma Protein Therapeutic Market share analysis by country, 2022
  • FIGURE India Plasma Protein Therapeutic Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE China Plasma Protein Therapeutic Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Japan Plasma Protein Therapeutic Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE South Korea Plasma Protein Therapeutic Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Australia Plasma Protein Therapeutic Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Thailand Plasma Protein Therapeutic Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Indonesia Plasma Protein Therapeutic Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Phillipines Plasma Protein Therapeutic Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Rest of APAC Plasma Protein Therapeutic Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Latin America Plasma Protein Therapeutic Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Latin America Plasma Protein Therapeutic Market share analysis by country, 2022
  • FIGURE Brazil Plasma Protein Therapeutic Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Mexico Plasma Protein Therapeutic Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Argentina Plasma Protein Therapeutic Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Colombia Plasma Protein Therapeutic Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Rest of LATAM Plasma Protein Therapeutic Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Middle East and Africa Plasma Protein Therapeutic Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Middle East and Africa Plasma Protein Therapeutic Market share analysis by country, 2022
  • FIGURE Saudi Arabia Plasma Protein Therapeutic Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE United Arab Emirates Plasma Protein Therapeutic Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Israel Plasma Protein Therapeutic Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Turkey Plasma Protein Therapeutic Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Algeria Plasma Protein Therapeutic Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Egypt Plasma Protein Therapeutic Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Rest of MEA Plasma Protein Therapeutic Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
目次
Product Code: ANV2094

REPORT HIGHLIGHT

Plasma Protein Therapeutic Market size was valued at USD 30,053 Million in 2023, expanding at a CAGR of 6.5% from 2024 to 2032.

Plasma protein therapies are exceptional biologic medications that are administered through infusion or injection to address a diverse range of uncommon, life-threatening, chronic, and genetic ailments. These conditions encompass bleeding disorders, immune deficiencies, pulmonary disorders, neurological disorders, shock and trauma, liver cirrhosis, as well as infectious diseases like tetanus, hepatitis, and rabies. The utilization of plasma-derived medicines is crucial for patients suffering from rare diseases that can solely be managed through these therapies. Moreover, these medicines play a vital role in everyday medical practices, emergency and critical care scenarios, and preventive medicine. On a daily basis, approximately 300,000 European patients heavily rely on plasma protein therapies to effectively treat various critical medical conditions. These conditions may include rare genetic diseases, chronic ailments, or life-threatening medical emergencies resulting from accidents and trauma. For these patients, plasma-derived medicines serve as a lifeline by aiding the body in replacing missing or deficient proteins. The absence of consistent access to these treatments would result in the loss of many lives or a significant decline in the quality of life for these individuals.

Plasma Protein Therapeutic Market- Market Dynamics

Increase in autoimmune disorders, immune deficiency disorders, neurological and bleeding disorders are projected to drive the growth of market.

Plasma protein therapeutics, such as plasma-derived immunoglobulins, are utilized in the treatment of specific autoimmune disorders. The rising prevalence of autoimmune diseases contributes to the increasing demand for plasma-based therapies, thereby propelling market expansion. Based on comprehensive research and data collected from countries with robust epidemiological resources, such as the Scandinavian countries, it is estimated that autoimmune diseases collectively affect approximately 3% of the US population, equivalent to around 10 million individuals. To better comprehend this estimation considers the current US population of 329 million. Additionally, the market is expected to witness a surge in the incidence of immune deficiency disorders, neurological disorders, and bleeding disorders, resulting in a larger patient pool necessitating therapeutic interventions. The prevalence of neurological disorders specifically can drive the demand for these therapeutic options. The prevalence rates of various neurological disorders across different regions of the country range from 967 to 4,070 per 100,000 population, with an average of 2,394, indicating that over 30 million people are affected by neurological disorders. Moreover, ongoing advancements in therapeutic technologies, such as the development of recombinant proteins and engineered plasma proteins, present opportunities for innovation within the market. However, it is important to note that the high cost of treatment and the potential risks of contamination and transmission may impede the growth of the market.

Plasma Protein Therapeutic Market- Key Insights

  • As per the analysis shared by our research analyst, the global Plasma Protein Therapeutic market is estimated to grow annually at a CAGR of around 6.5% over the forecast period (2024-2032)
  • Based on product type segmentation, Immunoglobulin was predicted to show maximum market share in the year 2023
  • Based on application segmentation, Primary Immunodeficiency Disorder (PIDD) was the leading type in 2023
  • On the basis of region, Asia pacific was the leading revenue generator in 2023

Plasma Protein Therapeutic Market- Segmentation Analysis:

The Global Plasma Protein Therapeutic Market is segmented on the basis of Product Type, Application and Region.

The market is divided into three categories based on product type: Albumin, Immunoglobulin, Plasma-derived Factor VIII and Others. The market is largely influenced by the dominance of the Immunoglobulin segment. Immunoglobulin products hold significant importance in the Plasma Protein Therapeutic market as they are vital in treating a range of medical conditions such as immunodeficiency disorders, autoimmune diseases, and neurological disorders.

The market is divided into two categories based on application: Hemophilia, Primary Immunodeficiency Disorder (PIDD), Idiopathic Thrombocytopenic Purpura (ITP) and Others. The market is primarily dominated by the segment of Primary Immunodeficiency Disorder (PIDD). In cases of PIDD, where the immune system is compromised, patients frequently experience a deficiency in antibodies. Immunoglobulin Replacement Therapy, which is derived from human plasma, plays a crucial role in the management of PIDD. This therapy entails the administration of immunoglobulins to bolster the patient's immune response.

Plasma Protein Therapeutic Market- Geographical Insights

Geographically, this market is spread across various regions including North America, Latin America, Europe, Asia Pacific, and the Middle East and Africa. These regions are further divided based on the countries involved in business activities. The growth of the market is expected to be dominated by the Asia Pacific region, primarily due to its well-established healthcare infrastructure and the focused efforts of market players in research and development for plasma protein therapeutics. In recent years, Asia Pacific has witnessed significant growth in its healthcare infrastructure, with investments being made in medical facilities, hospitals, and research centers, thereby contributing to the overall improvement of the healthcare ecosystem. Notably, the Chinese government has successfully established a robust healthcare system, which is quite challenging considering the country's status as the largest developing nation in the world. Through continuous efforts of successive governments, the Chinese mainland is projected to have a total of 1,030,935 healthcare institutions by the end of 2021, including 36,570 hospitals and 977,790 primary-level clinics. In terms of market size, Europe holds the second-largest position during the forecast period, driven by the increasing demand for advanced treatment options and the growth of developing economies.

Plasma Protein Therapeutic Market- Competitive Landscape:

In contrast to the conventional pharmaceutical industry, the plasma industry utilizes human blood plasma, a living cell, as its primary material for producing life-saving medications. The production of these medications relies on a limited supply of raw material, which is generally more expensive and complex to obtain compared to non-living molecules and biologics grown in biotechnology facilities. To remain competitive in the market, ongoing research and development efforts are crucial. Companies allocate investments towards the development of new and improved plasma-derived products, the enhancement of manufacturing processes, and the exploration of new therapeutic applications. Biotechnology advancements, such as the creation of recombinant proteins, are areas of focus for many companies as they strive to meet the increasing demand for safer and more sustainable treatment options. Companies with a global presence have an advantage in accessing diverse markets. They establish manufacturing facilities, distribution networks, and partnerships to ensure the availability of their products in various regions. As the demand for plasma-derived therapies continues to rise, companies are likely to persist in investing in research and development, exploring strategic partnerships, and adapting to evolving market dynamics to maintain their competitive edge.

Recent Advancements:

In May 2023, Biotest AG now has 28 nations on its market due to marketing authorizations it was granted to sell Cytotect, a CMV-hyper immunoglobulin, in five more countries: the Czech Republic, Slovakia, Lituania, Ireland, and Romania.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL PLASMA PROTEIN THERAPEUTIC MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS

  • CSL
  • Grifols, S.A.
  • Takeda
  • Octapharma AG
  • Biotest AG
  • Kedrion S.p.A

GLOBAL PLASMA PROTEIN THERAPEUTIC MARKET, BY PRODUCT TYPE- MARKET ANALYSIS, 2019 - 2032

  • Albumin
  • Immunoglobulin
  • Plasma-derived Factor VIII
  • Others

GLOBAL PLASMA PROTEIN THERAPEUTIC MARKET, BY APPLICATION- MARKET ANALYSIS, 2019 - 2032

  • Hemophilia
  • Primary Immunodeficiency Disorder (PIDD)
  • Idiopathic Thrombocytopenic Purpura (ITP)
  • Others

GLOBAL PLASMA PROTEIN THERAPEUTIC MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032

  • North America
  • The U.S.
  • Canada
  • Europe
  • Germany
  • France
  • Italy
  • Spain
  • United Kingdom
  • Russia
  • Netherlands
  • Sweden
  • Poland
  • Rest of Europe
  • Asia Pacific
  • India
  • China
  • South Korea
  • Japan
  • Australia
  • Thailand
  • Indonesia
  • Philippines
  • Rest of APAC
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Rest of LATAM
  • The Middle East and Africa
  • Saudi Arabia
  • United Arab Emirates
  • Israel
  • Turkey
  • Algeria
  • Egypt
  • Rest of MEA

Table of Contents

1. Plasma Protein Therapeutic Market Overview

  • 1.1. Study Scope
  • 1.2. Market Estimation Years

2. Executive Summary

  • 2.1. Market Snippet
    • 2.1.1. Plasma Protein Therapeutic Market Snippet by Product Type
    • 2.1.2. Plasma Protein Therapeutic Market Snippet by Application
    • 2.1.3. Plasma Protein Therapeutic Market Snippet by Country
    • 2.1.4. Plasma Protein Therapeutic Market Snippet by Region
  • 2.2. Competitive Insights

3. Plasma Protein Therapeutic Key Market Trends

  • 3.1. Plasma Protein Therapeutic Market Drivers
    • 3.1.1. Impact Analysis of Market Drivers
  • 3.2. Plasma Protein Therapeutic Market Restraints
    • 3.2.1. Impact Analysis of Market Restraints
  • 3.3. Plasma Protein Therapeutic Market Opportunities
  • 3.4. Plasma Protein Therapeutic Market Future Trends

4. Plasma Protein Therapeutic Industry Study

  • 4.1. PEST Analysis
  • 4.2. Porter's Five Forces Analysis
  • 4.3. Growth Prospect Mapping
  • 4.4. Regulatory Framework Analysis

5. Plasma Protein Therapeutic Market: COVID-19 Impact Analysis

  • 5.1. Pre-COVID-19 Impact Analysis
  • 5.2. Post-COVID-19 Impact Analysis
    • 5.2.1. Top Performing Segments
    • 5.2.2. Marginal Growth Segments
    • 5.2.3. Top Looser Segments
    • 5.2.4. Marginal Loss Segments

6. Plasma Protein Therapeutic Market Landscape

  • 6.1. Plasma Protein Therapeutic Market Share Analysis, 2022
  • 6.2. Breakdown Data, by Key Manufacturer
    • 6.2.1. Established Players' Analysis
    • 6.2.2. Emerging Players' Analysis

7. Plasma Protein Therapeutic Market - By Product Type

  • 7.1. Overview
    • 7.1.1. Segment Share Analysis, By Product Type, 2022 & 2030 (%)
    • 7.1.2. Albumin
    • 7.1.3. Immunoglobulin
    • 7.1.4. Plasma-derived Factor VIII
    • 7.1.5. Others

8. Plasma Protein Therapeutic Market - By Application

  • 8.1. Overview
    • 8.1.1. Segment Share Analysis, By Application, 2022 & 2030 (%)
    • 8.1.2. Hemophilia
    • 8.1.3. Primary Immunodeficiency Disorder (PIDD)
    • 8.1.4. Idiopathic Thrombocytopenic Purpura (ITP)
    • 8.1.5. Others

9. Plasma Protein Therapeutic Market- By Geography

  • 9.1. Introduction
    • 9.1.1. Segment Share Analysis, By Geography, 2022 & 2030 (%)
  • 9.2. North America
    • 9.2.1. Overview
    • 9.2.2. Plasma Protein Therapeutic Key Manufacturers in North America
    • 9.2.3. North America Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 9.2.4. North America Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
    • 9.2.5. North America Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 9.2.6. U.S.
      • 9.2.6.1. Overview
      • 9.2.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.2.6.3. U.S. Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 9.2.6.4. U.S. Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 9.2.7. Canada
      • 9.2.7.1. Overview
      • 9.2.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.2.7.3. Canada Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 9.2.7.4. Canada Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
  • 9.3. Europe
    • 9.3.1. Overview
    • 9.3.2. Plasma Protein Therapeutic Key Manufacturers in Europe
    • 9.3.3. Europe Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 9.3.4. Europe Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
    • 9.3.5. Europe Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 9.3.6. Germany
      • 9.3.6.1. Overview
      • 9.3.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.3.6.3. Germany Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 9.3.6.4. Germany Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 9.3.7. Italy
      • 9.3.7.1. Overview
      • 9.3.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.3.7.3. Italy Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 9.3.7.4. Italy Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 9.3.8. United Kingdom
      • 9.3.8.1. Overview
      • 9.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.3.8.3. United Kingdom Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 9.3.8.4. United Kingdom Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 9.3.9. France
      • 9.3.9.1. Overview
      • 9.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.3.9.3. France Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 9.3.9.4. France Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 9.3.10. Russia
      • 9.3.10.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.3.10.2. Russia Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 9.3.10.3. Russia Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 9.3.11. Netherlands
      • 9.3.11.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.3.11.2. Netherlands Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 9.3.11.3. Netherlands Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 9.3.12. Sweden
      • 9.3.12.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.3.12.2. Sweden Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 9.3.12.3. Sweden Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 9.3.13. Poland
      • 9.3.13.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.3.13.2. Poland Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 9.3.13.3. Poland Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 9.3.14. Rest of Europe
      • 9.3.14.1. Overview
      • 9.3.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.3.14.3. Rest of the Europe Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 9.3.14.4. Rest of the Europe Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
  • 9.4. Asia Pacific (APAC)
    • 9.4.1. Overview
    • 9.4.2. Plasma Protein Therapeutic Key Manufacturers in Asia Pacific
    • 9.4.3. Asia Pacific Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 9.4.4. Asia Pacific Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
    • 9.4.5. Asia Pacific Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 9.4.6. India
      • 9.4.6.1. Overview
      • 9.4.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.4.6.3. India Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 9.4.6.4. India Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 9.4.7. China
      • 9.4.7.1. Overview
      • 9.4.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.4.7.3. China Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 9.4.7.4. China Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 9.4.8. Japan
      • 9.4.8.1. Overview
      • 9.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.4.8.3. Japan Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 9.4.8.4. Japan Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 9.4.9. South Korea
      • 9.4.9.1. Overview
      • 9.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.4.9.3. South Korea Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 9.4.9.4. South Korea Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 9.4.10. Australia
      • 9.4.10.1. Overview
      • 9.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.4.10.3. Australia Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 9.4.10.4. Australia Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 9.4.11. Thailand
      • 9.4.11.1. Overview
      • 9.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.4.11.3. Thailand Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 9.4.11.4. Thailand Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 9.4.12. Indonesia
      • 9.4.12.1. Overview
      • 9.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.4.12.3. Indonesia Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 9.4.12.4. Indonesia Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 9.4.13. Philippines
      • 9.4.13.1. Overview
      • 9.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.4.13.3. Philippines Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 9.4.13.4. Philippines Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 9.4.14. Rest of APAC
      • 9.4.14.1. Overview
      • 9.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.4.14.3. Rest of APAC Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 9.4.14.4. Rest of APAC Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
  • 9.5. Latin America
    • 9.5.1. Overview
    • 9.5.2. Plasma Protein Therapeutic Key Manufacturers in Latin America
    • 9.5.3. Latin America Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 9.5.4. Latin America Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
    • 9.5.5. Latin America Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 9.5.6. Brazil
      • 9.5.6.1. Overview
      • 9.5.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.5.6.3. Brazil Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 9.5.6.4. Brazil Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 9.5.7. Mexico
      • 9.5.7.1. Overview
      • 9.5.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.5.7.3. Mexico Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 9.5.7.4. Mexico Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 9.5.8. Argentina
      • 9.5.8.1. Overview
      • 9.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.5.8.3. Argentina Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 9.5.8.4. Argentina Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 9.5.9. Colombia
      • 9.5.9.1. Overview
      • 9.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.5.9.3. Colombia Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 9.5.9.4. Colombia Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 9.5.10. Rest of LATAM
      • 9.5.10.1. Overview
      • 9.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.5.10.3. Rest of LATAM Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 9.5.10.4. Rest of LATAM Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
  • 9.6. Middle East and Africa
    • 9.6.1. Overview
    • 9.6.2. Plasma Protein Therapeutic Key Manufacturers in Middle East and Africa
    • 9.6.3. Middle East and Africa Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 9.6.4. Middle East and Africa Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
    • 9.6.5. Middle East and Africa Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 9.6.6. Saudi Arabia
      • 9.6.6.1. Overview
      • 9.6.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.6.6.3. Saudi Arabia Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 9.6.6.4. Saudi Arabia Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 9.6.7. United Arab Emirates
      • 9.6.7.1. Overview
      • 9.6.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.6.7.3. United Arab Emirates Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 9.6.7.4. United Arab Emirates Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 9.6.8. Israel
      • 9.6.8.1. Overview
      • 9.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.6.8.3. Israel Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 9.6.8.4. Israel Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 9.6.9. Turkey
      • 9.6.9.1. Overview
      • 9.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.6.9.3. Turkey Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 9.6.9.4. Turkey Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 9.6.10. Algeria
      • 9.6.10.1. Overview
      • 9.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.6.10.3. Algeria Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 9.6.10.4. Algeria Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 9.6.11. Egypt
      • 9.6.11.1. Overview
      • 9.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.6.11.3. Egypt Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 9.6.11.4. Egypt Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 9.6.12. Rest of MEA
      • 9.6.12.1. Overview
      • 9.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.6.12.3. Rest of MEA Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 9.6.12.4. Rest of MEA Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)

10. Key Vendor Analysis- Plasma Protein Therapeutic Industry

  • 10.1. Competitive Dashboard
  • 10.2. Company Profiles
    • 10.2.1. CSL
    • 10.2.2. Grifols, S.A.
    • 10.2.3. Takeda
    • 10.2.4. Octapharma AG
    • 10.2.5. Biotest AG
    • 10.2.6. Kedrion S.p.A

11. 360 Degree Analyst View

12. Appendix

  • 12.1. Research Methodology
  • 12.2. References
  • 12.3. Abbreviations
  • 12.4. Disclaimer
  • 12.5. Contact Us